- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Coronavirus infection may lead to fibrotic changes and damage to kidney
![Coronavirus infection may lead to fibrotic changes and damage to kidney Coronavirus infection may lead to fibrotic changes and damage to kidney](https://medicaldialogues.in/h-upload/2021/06/01/750x450_155039-kidney.webp)
The Coronavirus SARS-CoV-2 infects the kidneys and contributes to tissue scarring, as shown by researchers from the RWTH Uniklinik Aachen, Germany, and Radboudumc, The Netherlands. The developed scar tissue in the infected kidneys may suggest a possible impact on kidney outcomes in the long term.
The fact that the Coronavirus can result in severe damage in the human body is known, and also that kidneys can get infected. But what exactly happens in the kidney as a result of the infection, remains elusive until now. In this study, published in Cell Stem Cell, researchers investigated the kidney tissue of COVID-19 patients admitted to the Intensive Care Unit. They found scarring of the tissue as compared to Intensive Care patients with a non-COVID-19 lung infection and a control group.
Next, the researchers questioned what exactly the cause was of the kidney damage. Could this be a direct effect of the virus, independent of systemic inflammation? To investigate this, the researchers cultured mini kidneys in the lab, called organoids. The kidney organoids are developed from stem cells and contain many different kidney cells, except immune cells. The kidney organoids were infected with SARS-CoV-2 and the researchers investigated the direct effect of the virus on the kidney cells, independent of potential secondary effects caused by immune cells or other systemic effects. The researchers found, in line with the COVID-19 patient tissues, scarring of the kidney organoids and accompanied signals that contribute to the scarring process.
The results of this study indicate that the recent finding of another USA based large cohort study that reported kidney functional decline in over 90,000 COVID-19 survivors (Bowe et al JASN) might be due to direct effects of the SARS-CoV2 virus on the kidney causing scar formation.
Researcher Jitske Jansen (Radboudumc): "In our study, we thoroughly investigated the causal damaging effects of the Coronavirus in the kidneys. The infected kidney organoids show that the virus directly causes cell damage, independent of the immune system. With this work, we found a piece of the puzzle showing the deleterious effects the virus can have in the body". Researcher Katharina Reimer (RWTH Aachen Uniklinik): "Kidney fibrosis, or scarring, is a serious long-term consequence that can occur virtually after any injury to the kidney and correlates with kidney function. Our work shows kidney scarring in COVID-19 patients, which provides an explanation why the virus might cause kidney functional decline as demonstrated in other studies. Long-term follow-up studies will provide further insights into kidney-related pathologies caused by SARS-CoV-2".
Hina Zahid Joined Medical Dialogue in 2017 with a passion to work as a Reporter. She coordinates with various national and international journals and association and covers all the stories related to Medical guidelines, Medical Journals, rare medical surgeries as well as all the updates in the medical field. Email:Â editorial@medicaldialogues.in. Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: editorial@medicaldialogues.in. Contact no. 011-43720751